Plant ID: NPO6328
Plant Latin Name: Corydalis incisa
Taxonomy Genus: Corydalis
Taxonomy Family: Papaveraceae
NCBI TaxonomyDB:
404570
Plant-of-the-World-Online:
n.a.
Miscellany
China
DRD1; | |
MTOR; | |
TP53; | |
SMN1;SMN2; | |
THPO; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Small molecule receptor (family A GPCR) | DRD1 | Dopamine D1 receptor | P21728 | CHEMBL2056 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.398E-09 | 3.044E-05 | CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 9.828E-07 | 1.070E-02 | CYP1A2, CYP2C19, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 4.048E-06 | 2.099E-02 | CYP1A2, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 8.667E-06 | 2.099E-02 | CYP1A2, CYP2C19 |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 1.244E-05 | 2.099E-02 | LMNA, MTOR, TP53 |
BP | GO:0008152; metabolic process | GO:0042737; drug catabolic process | 1.639E-05 | 2.099E-02 | CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0005488; binding | GO:0020037; heme binding | 2.319E-05 | 2.525E-02 | CYP1A2, CYP2C19, CYP2D6 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 2.616E-05 | 2.713E-02 | CYP1A2, CYP2C19, CYP2D6, DRD1, MTOR |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 4.517E-05 | 3.513E-02 | CYP1A2, CYP2C19, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 4.858E-05 | 3.648E-02 | CYP1A2, CYP2D6 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.074E-04 | 6.880E-02 | CYP2C19, CYP2D6 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 4.404E-04 | 1.336E-01 | CYP1A2, CYP2C19, CYP2D6, DRD1, LMNA, MTOR |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 3.253E-06 | 2.439E-04 | CYP2D6, CYP1A2, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05214 | Glioma | 3.690E-04 | 6.979E-03 | TP53, MTOR |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 7.262E-05 | 2.723E-03 | CYP1A2, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 3.920E-04 | 6.979E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 6.907E-04 | 7.220E-03 | TP53, MTOR |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.653E-04 | 6.979E-03 | CYP2D6, CYP1A2 |
09150 Organismal Systems | 09149 Aging | hsa04211 | Longevity regulating pathway - mammal | 7.701E-04 | 7.220E-03 | TP53, MTOR |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 5.867E-04 | 7.220E-03 | CYP1A2, CYP2C19 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.091E-03 | 9.070E-03 | CYP2D6, CYP2C19 |
09150 Organismal Systems | 09152 Endocrine system | hsa04919 | Thyroid hormone signaling pathway | 1.209E-03 | 9.070E-03 | TP53, MTOR |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | DRD1; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | DRD1; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Substance dependence | F10-F19 | DRD1; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
O00-O9A: Pregnancy, childbirth and the puerperium | Excessive bleeding following childbirth and spontaneous or elective abortion | O04 | DRD1; |
I00-I99: Diseases of the circulatory system | Hypertension | I10-I16 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Dementia | F01-F07 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Schizophrenia | F20 | DRD1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Psychiatric disorder | F01-F99 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cocaine addiction | F14.2 | DRD1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Psychotic disorders | F20-F29 | DRD1; |